The BrioVAD pump is the first implantable device from China to receive approval for clinical trials in America.

Since its creation, it has operated continuously and simulated billions of heartbeats, offering new hope to patients suffering from end-stage heart failure.

The BrioVAD pump is the first implantable device from China to receive approval for clinical trials in America.